183 related articles for article (PubMed ID: 26168721)
1. Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.
Kovalchuk Ben-Zaken O; Nissan I; Tzaban S; Taraboulos A; Zcharia E; Matzger S; Shafat I; Vlodavsky I; Tal Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):698-704. PubMed ID: 26168721
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
[TBL] [Abstract][Full Text] [Related]
3. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
4. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
5. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
6. PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.
Paquet S; Daude N; Courageot MP; Chapuis J; Laude H; Vilette D
J Virol; 2007 Oct; 81(19):10786-91. PubMed ID: 17626095
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
8. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
9. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
Cronier S; Laude H; Peyrin JM
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
[TBL] [Abstract][Full Text] [Related]
10. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
11. Copper binding to PrPC may inhibit prion disease propagation.
Hijazi N; Shaked Y; Rosenmann H; Ben-Hur T; Gabizon R
Brain Res; 2003 Dec; 993(1-2):192-200. PubMed ID: 14642846
[TBL] [Abstract][Full Text] [Related]
12. Copaxone interferes with the PrP Sc-GAG interaction.
Engelstein R; Ovadia H; Gabizon R
Eur J Neurol; 2007 Aug; 14(8):877-84. PubMed ID: 17662008
[TBL] [Abstract][Full Text] [Related]
13. Is the prion structure solved?
Liberski PP; Bratosiewicz-Zapart J
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):121-40. PubMed ID: 9597078
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
16. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
17. Prion protein amyloid: separation of scrapie infectivity from PrP polymers.
Wille H; Baldwin MA; Cohen FE; DeArmond SJ; Prusiner SB
Ciba Found Symp; 1996; 199():181-99; discussion 199-201. PubMed ID: 8915611
[TBL] [Abstract][Full Text] [Related]
18. Involvement of glypican-1 autoprocessing in scrapie infection.
Löfgren K; Cheng F; Fransson LA; Bedecs K; Mani K
Eur J Neurosci; 2008 Sep; 28(5):964-72. PubMed ID: 18717736
[TBL] [Abstract][Full Text] [Related]
19. Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types.
Kercher L; Favara C; Chan CC; Race R; Chesebro B
Am J Pathol; 2004 Dec; 165(6):2055-67. PubMed ID: 15579448
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.
Race B; Phillips K; Kraus A; Chesebro B
Prion; 2016 Jul; 10(4):319-30. PubMed ID: 27463540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]